Fundraising Fox
Find your path to Jamie
Sign up to see every warm intro you have to Jamie
- Paths you didn't know you had: your email and LinkedIn already hold routes to Jamie. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Jamie Stiff joined Genesys Capital in 2002 and became Partner in 2007, leading investments in early-stage life sciences companies and serving on numerous portfolio company boards. He previously worked in genetic diagnostics at the Samuel Lunenfeld Research Institute and holds a BSc from Queen's University and an MBA from the Rotman School of Management.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Allostera PharmaEbt MedicalEnspiredbsFairhaven PharmaceuticalsFeldan TherapeuticsgIcare PharmaGiiant Pharma Inc.Interface BiologicsInversago PharmaMatregenNaurexNeurAxonStemPathTherapeutic Monitoring SystemsVeralox Therapeutics, Inc.Zelos Therapeutics
Per the firm's website.
Colleagues at Genesys Capital
Frequently asked questions
- Who is Jamie Stiff?
- Jamie Stiff joined Genesys Capital in 2002 and became Partner in 2007, leading investments in early-stage life sciences companies and serving on numerous portfolio company boards. He previously worked in genetic diagnostics at the Samuel Lunenfeld Research Institute and holds a BSc from Queen's University and an MBA from the Rotman School of Management.
- Where does Jamie Stiff work?
- Jamie Stiff is Managing Director at Genesys Capital.
- What does Jamie Stiff invest in?
- Jamie Stiff invests in Biotech, Healthtech, Medical Devices.
- What boards does Jamie Stiff sit on?
- Jamie Stiff holds tracked board seats at Allostera Pharma, Ebt Medical, Enspiredbs, Fairhaven Pharmaceuticals, Feldan Therapeutics, gIcare Pharma, Giiant Pharma Inc., Interface Biologics, Inversago Pharma, Matregen.
About this profile. Compiled from public sources — Genesys Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights